Sectors
Healthcare and life sciences are connected, but not interchangeable. The same growth or performance question can have a different answer depending on who makes the decision, how care is delivered, what evidence is trusted and how the economics work.
LM Qantara works across three connected areas, particularly where products, care models or ideas need to move between markets, professional audiences or healthcare settings.
Healthcare services and care delivery
In healthcare services, strategy becomes operational quickly. Growth can fail because referral paths are unclear, capacity sits in the wrong place, workflows vary or a model cannot scale without overloading teams.
We work selectively with provider groups, clinic networks and specialty-care platforms on site performance, patient journeys, capacity, service flow and what should be standardised across a network.
Our perspective combines direct owner-operator experience in veterinary healthcare with commercial strategy experience in human health. The settings differ, but many operating mechanics are shared across professional-led care. Where regulatory, reimbursement or clinical-governance expertise is material, we bring it in selectively.
Animal health, veterinary care and the pet economy
Animal-health opportunities succeed or fail for different reasons depending on where the decision sits. A companion-animal product may turn on veterinary confidence and clinic workflow; livestock vaccination may depend on surveillance, regulation, production structures and alignment with public authorities.
We work at the level shaping the outcome:
- product and route to market
- clinic, care model or customer journey
- the wider system of producers, authorities, regulators and industry
At system level, market analysis alone is not enough; strategy must connect market structure and stakeholder dynamics with adoption and implementation.
Our perspective spans clinical practice, veterinary business ownership, multisite care, commercial strategy and investment, reinforced by a strong network across the wider animal-health community that can bring in practitioner, industry, scientific or institutional perspectives when needed.
Pharmaceuticals, life sciences and health technologies
The market on paper can look very different from the market a company can actually reach. Approved products can still fall short because access varies, patients are lost along the pathway, or the evidence does not answer the questions that drive adoption. Medical technologies face similar issues when the right use case, customer, price or channel is unclear.
We work across portfolio focus, market entry and adoption, combining pharmaceutical commercial strategy with experience in medical products, biomaterials and clinically led market development. The value is in bringing scientific and clinical understanding alongside commercial judgement, and adapting the answer to different healthcare systems and professional behaviours.
Get in touch
For project enquiries or to discuss a potential engagement, we’d be happy to hear from you.